Merus Labs International Inc.
Merus Labs International Inc., commonly referred to as Merus Labs, is a prominent pharmaceutical company headquartered in Canada. Founded in 2014, the company has established a strong presence in the specialty pharmaceuticals sector, focusing on the development and commercialisation of innovative therapies. With operations primarily in North America and Europe, Merus Labs is dedicated to providing high-quality products that address unmet medical needs. Their core offerings include a range of prescription medications, particularly in the areas of dermatology and infectious diseases, distinguished by their unique formulations and delivery methods. Merus Labs has achieved significant milestones, including strategic partnerships and a robust portfolio of proprietary products, positioning itself as a key player in the pharmaceutical industry. The company’s commitment to improving patient outcomes underscores its reputation for excellence and innovation in healthcare.
DitchCarbon Score
How does Merus Labs International Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Merus Labs International Inc.'s score of 30 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Merus Labs International Inc.'s reported carbon emissions
In 2023, Merus Labs International Inc. reported carbon emissions totalling approximately 33,051,085 kg CO2e from Scope 3 sources, while Scope 2 emissions were about 30,928 kg CO2e. Notably, the company recorded no emissions under Scope 1. This pattern of emissions has remained consistent over the previous years, with identical figures for Scope 2 and Scope 3 emissions reported in 2021 and 2022. Despite the significant Scope 3 emissions, Merus Labs has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of defined climate commitments or pledges suggests that the company may be in the early stages of developing a comprehensive sustainability strategy. As the industry increasingly prioritises climate action, Merus Labs' current emissions profile highlights the need for enhanced transparency and commitment to reducing greenhouse gas emissions in line with global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | - | - | - |
| Scope 2 | 30,928 | 00,000 | 00,000 |
| Scope 3 | 33,051,085 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Merus Labs International Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
